1. Kauffman CA. Endemic mycoses: blastomycosis,
histoplasmosis, and sporotrichosis. Infect Dis Clin North
Am. 2006;20(3):645-662.
2. Ajello L. Distribution of Histoplasma capsulatum in
the United States. In: Histoplasmosis. Proceedings of the
Second National Conference. Springfield, IL: Charles C
Thomas; 1971.
3. Schlech WF 3rd, Wheat LJ, Ho JL, et al. Recurrent urban histoplasmosis,
Indianapolis, Indiana, 1980–1981. Am J Epidemiol.
1983;118(3):301-312.
4. Sathapatayavongs B, Batteiger BE, Wheat LJ, et al. Clinical
and laboratory features of disseminated histoplasmosis during two
large urban outbreaks. Medicine (Baltimore). 1983;62(5):263-270.
5. Chamany S, Mirza SA, Fleming JW, et al. A large histoplasmosis
outbreak among high school students in Indiana, 2001. Pediatr
Infect Dis J. 2004;23(10):909-914.
6. Cano MVC, Hajjeh RA. The epidemiology of histoplasmosis:
A review. Semin Respir Dis. 2001;16 (2):109-118.
7. Wheat LJ, Freifeld AG, Kleiman MB, et al. Management of patients
with histoplasmosis: clinical practice guidelines by the Infectious
Disease Society of America. Clin Infect Dis. 2007;45(7):807-825.
8. Wheat LJ, Conces D, Allen SD, Blue-Hnidy D, Loyd J. Pulmonary
histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir
Crit Care Med. 2004;25(2):129-144.
9. Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment
with anti-tumor necrosis factor-α therapy. Am
J Respir Crit Care Med. 2003;167(9):1279-1282.
10. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation
of maintenance therapy for disseminated histoplasmosis after immunologic
response to antiretroviral therapy. Clin Infect Dis.
2004;38(10):1485-1489.
11. de Francesco Daher E, de Sousa Barros FA, da Silva Junior
GB, et al. Risk factors for death in acquired immunodeficiency syndrome-associated
disseminated histoplasmosis. Am J Trop Med Hyg.
2006;74(4):600-603.
12. Tobon AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis:
a comparative study between patients with acquired immunodeficiency
syndrome and non-human immunodeficiency virus-infected individuals. Am
J Trop Med Hyg. 2005;73(3):576-582.
13. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune
reconstitution syndrome in HIV: validating a case definition and
identifying clinical predictors in persons initiating antiretroviral
therapy. Clin Infect Dis. 2006;42(11):1639-1646.
14. Adderson EE. Histoplasmosis in a pediatric oncology center. J
Pediatr. 2004;144(1):100-106.
15. Odio CM, Navarrete M, Carrillo JM, et al. Disseminated histoplasmosis
in infants. Pediatr Infect Dis J. 1999;18(12):1065-1068.
16. Kahi CJ, Wheat LJ, Allen SD, Sarosi GA. Gastrointestinal
histoplasmosis. Am J Gastroenterol. 2005;100(1):220-231.
17. Wheat LJ. Improvements in diagnosis of histoplasmosis. Expert
Opin Biol Ther. 2006;6(11):1207-1221.
18. Gaebler JW, Kleiman MB, Cohen M, et al. Differentiation
of lymphoma from histoplasmosis in children with mediastinal masses. J
Pediatr. 1984;104(5):706-709.
19. Wheat LJ. Antigen detection, serology, and molecular diagnosis
of invasive mycoses in the immunocompromised host. Transpl
Infect Dis. 2006;8(3):128-139.
20. Connolly PA, Durkin MM, LeMonte AM, Hackett EJ, Wheat LJ.
Detection of Histoplasma antigen by a quantitative enzyme immunoassay. Clin
Vaccine Immunol. 2007;14(12):1587-1591.
21. Fojtasek MF, Kleiman MB, Connolly-Stringfield P, et al.
The Histoplasma capsulatum antigen assay in disseminated histoplasmosis
in children. Pediatr Infect Dis J. 1994;13(9):801-805.
22. US Department of Health and Human Services. Histoplasmosis:
Protecting Workers at Risk. Washington, DC: National Institute
of Occupational Safety and Health; 1997. DHHS (NIOSH) Publication
97-146.
23. Prasad AG, Van Gelder RN. Presumed ocular histoplasmosis
syndrome. Curr Opin Ophthalmol. 2005;16(6):364-368.